Inventor · disambiguated record
Jerry Ryan Holder
Also filed as: HOLDER JERRY RYAN
10 granted patents·6 pending applications·52 citations·filing 2002–2025
85Inventor score
Top patents by PatentIndex Score
16 records- 0190US10905772B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2018·Granted Feb 2, 2021·6 cites·18 claims
- 0288US7368433B2Peptides and methods for the control of obesityUNIV FLORIDA·Filed 2005·Granted May 6, 2008·11 cites·9 claims
- 0385US7034004B2Peptides and methods for the control of obesityUNIV FLORIDA·Filed 2002·Granted Apr 25, 2006·12 cites·12 claims
- 0484US8168592B2CGRP peptide antagonists and conjugatesGEGG JR COLIN V·Filed 2006·Granted May 1, 2012·23 cites·11 claims
- 0580US2024327461A1Apelin polypeptidesAMGEN INC·Filed 2024·Application pending·0 cites
- 0680US2025121056A1Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)AMGEN INC·Filed 2024·Application pending·0 cites
- 0778US2025319196A1Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (gipr)/glp-1 receptor agonist fusion proteinsAMGEN INC·Filed 2025·Application pending·0 cites
- 0878US2024261421A1Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (gipr)/glp-1 receptor agonist fusion proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 0974US11807693B2Apelin polypeptidesAMGEN INC·Filed 2021·Granted Nov 7, 2023·0 cites·6 claims
- 1069US12214051B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Feb 4, 2025·0 cites·14 claims
- 1165US12465652B2Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR)/GLP-1 receptor agonist fusion proteinsAMGEN INC·Filed 2018·Granted Nov 11, 2025·0 cites·20 claims
- 1262US2024084301A1Rnai constructs and methods for inhibiting fam13a expressionAMGEN INC·Filed 2023·Application pending·0 cites
- 1359US10941182B2Apelin polypeptidesAMGEN INC·Filed 2015·Granted Mar 9, 2021·0 cites·26 claims
- 1446US9636418B2Potent and selective inhibitors of NAV1.7AMGEN INC·Filed 2014·Granted May 2, 2017·0 cites·24 claims
- 1543US10344060B2Potent and selective inhibitors of Nav1.7AMGEN INC·Filed 2014·Granted Jul 9, 2019·0 cites·25 claims
- 1643US2016067347A1Apj receptor agonists and uses thereofAMGEN INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →